{{author}}{{author}}{{($index > metadata.AuthorsAndEtalArray.length-1) ? ',' : '.'}}

Suzanne Hagen, Carol Bugge, Sarah G Dean, Andrew Elders, Jean Hay-Smith, Mary Kilonzo, Doreen McClurg, Mohamed Abdel-Fattah, Wael Agur, Federico Andreis, Joanne Booth, Maria Dimitrova, Nicola Gillespie, Cathryn Glazener, Aileen Grant, Karen L Guerrero, Lorna Henderson, Marija Kovandzic, Alison McDonald, John Norrie, Nicole Sergenson, Susan Stratton, Anne Taylor & Louise R Williams.

Suzanne Hagen ^1,*, Carol Bugge ², Sarah G Dean ³, Andrew Elders ¹, Jean Hay-Smith ⁴, Mary Kilonzo ⁵, Doreen McClurg ¹, Mohamed Abdel-Fattah ⁵, Wael Agur ⁶, Federico Andreis ², Joanne Booth ⁷, Maria Dimitrova ⁵, Nicola Gillespie ¹, Cathryn Glazener ⁸, Aileen Grant ⁹, Karen L Guerrero ¹⁰, Lorna Henderson ¹¹, Marija Kovandzic ², Alison McDonald ¹¹, John Norrie ¹², Nicole Sergenson ¹, Susan Stratton ¹, Anne Taylor ², Louise R Williams ¹

¹ Nursing, Midwifery and Allied Health Professions Research Unit, Glasgow Caledonian University, Glasgow, UK
² Faculty of Health Sciences and Sport, University of Stirling, Stirling, UK
³ University of Exeter Medical School, Exeter, UK
⁴ Rehabilitation Teaching and Research Unit, University of Otago, Dunedin, New Zealand
⁵ Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK
⁶ NHS Ayrshire and Arran, Kilmarnock, UK
⁷ School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK
⁸ Health Services Research Unit, University of Aberdeen, Aberdeen, UK
⁹ School of Nursing and Midwifery, Robert Gordon University, Aberdeen, UK
¹⁰ Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, UK
¹¹ Centre for Healthcare Randomised Trials (CHaRT), Health Services Research Unit, University of Aberdeen, Aberdeen, UK
¹² Edinburgh Clinical Trials Unit, University of Edinburgh, Edinburgh, UK
^* Corresponding author Email: hagen@gcu.ac.uk

Declared competing interests of authors: Sarah G Dean reports funding from University College London for consultancy work as part of an expert panel in the behaviour change technique taxonomy development, Medical Research Council-funded project (2012–2015) outside the submitted work. Mohamed Abdel-Fattah reports having been, in the past, a speaker, consultant and surgical trainer for Astellas Pharma Inc. (Tokyo, Japan), Bard Medical Division (Covington, GA, USA), Pfizer Inc. (New York, NY, USA), American Medical Systems Inc. (Minnetonka, MN, USA) and Coloplast Ltd (Peterborough, UK). At that time, he was reimbursed travel expenses, received limited personal honorariums for some work, and, on occasions, received sponsorship towards attending scientific conferences. He has received a research grant from Coloplast, managed by the or received assistance University of Aberdeen. A limited number of his trainees attended pharmaceutical-sponsored educational/leadership workshops and/towards presenting their research work in scientific conferences. He was also the chairperson of the Scottish Pelvic Floor Network, which, at the time (up to 2014), received sponsorship from various industrial companies to exhibit in annual meetings and surgical workshops. In addition, he receives travel sponsorship from numerous national and international conferences and non-profit organisations when invited as guest speaker and/or expert surgeon. Wael Agur reports non-financial support from Astellas Pharma; personal fees from Johnson & Johnson (New Brunswick, NJ, USA) – Ethicon Endoscopy; personal fees from Specialty European Pharma Ltd/Contura Ltd (London, UK); personal fees and non-financial support from the Chief Scientist Office (Edinburgh, UK), NHS Research Scotland and NHS Ayrshire & Arran; grants from the National Institute for Health Research (NIHR); grants from the University of Stirling; personal fees from London Medical Education Academy (London, UK); personal fees from the Central Legal Office, NHS Scotland; personal fees from various law firms acting on behalf of mesh manufacturers, patient claimants and defendant clinicians in Scotland, England, Wales, Northern Ireland, the Republic of Ireland, USA and Australia; personal fees from Oaklaw Consultancy Ltd (Kilmarnock, UK) (dealing with medicolegal consultancy through a third party – Medico-legal Administration Service). Karen L Guerrero reports personal speaker fees, outside the submitted work, and educational bursaries from Contura Ltd to attend continuing professional development meetings. She is also course director/faculty member for Glasgow Urogynaecology/NHS Education Scotland courses/training days and meetings and NHS/Deanery Educational courses, which have had industry sponsorship. In addition, she is Treasurer for the UK Continence Society, the British Society of Urogynaecology Educational Committee Chair elect, Secretary of the Scottish Pelvic Floor Network and sits on the Royal College of Obstetricians and Gynaecologists subspecialty training committee. All of these associations/charities have meetings supported by industry. Furthermore, she is co-grant holder for several NIHR grants. John Norrie reports grants from the University of Aberdeen, and the University of Edinburgh during the conduct of the study; and declares membership of the following NIHR boards: Cardiopulmonary Resuscitation Decision-making Committee (2016), Health Technology Assessment (HTA) Commissioning Board (2010–16), HTA Commissioning Sub-Board (Expression of Interest) (2016–19), HTA Funding Boards Policy Group (2016–19), HTA General Board (2016–19), HTA Post-Board funding teleconference (2016–19), NIHR Clinical Trials Unit Standing Advisory Committee (2018–present), NIHR HTA and Efficacy and Mechanism Evaluation Editorial Board (2014–19) and the Pre-exposure Prophylaxis Impact Review Panel (2017–present).